Court annuls European Commission's refusal to disclose COVID texts

• NY Times seeking access to texts between Commission and Pfizer
• Commission's Von der Leyen says texts not in her possession
• Transparency advocates applaud decision

BRUSSELS, May 14 (Reuters) - The EU's General Court annulled on Wednesday a European Commission decision not to disclose text messages Commission President Ursula von der Leyen and the CEO of Pfizer (PFE.N)

Make sense of the latest ESG trends affecting companies and governments with the Reuters Sustainable Switch newsletter. Sign up here.

The Luxembourg-based court said the Commission, which negotiated vaccine contracts on behalf of the 27-nation bloc during the pandemic, did not provide credible reasons for rejecting a New York Times request to hand over the texts.

Von der Leyen has said she could not disclose the messages, which the court considered to be official EU documents, because she did not have them.

The court, however, said the Commission had failed to plausibly justify why the texts were no longer in her possession.

"The Commission has not explained in detail the type of searches that it carried out to find those documents or the identity of the places where those searches took place," it wrote in its ruling.

Some EU lawmakers have criticised the Commission's handling of the vaccine deals signed at the height of the pandemic, including a contract with Pfizer and BioNTech (22UAy.DE)

, opens new tab to buy up to 1.8 billion doses of their vaccines in May 2021.

The New York Times had requested access to text messages from Jan. 1, 2021 to May 11, 2022 between von der Leyen and Pfizer's Albert Bourla in an effort to shed light on the multi-billion-euro vaccine deal.

The New York Times applauded Wednesday's decision, calling it "a victory for transparency and accountability in the European Union".

The European Commission said it would closely study the ruling by the General Court - the EU's second-highest court - and "adopt a new decision providing a more detailed explanation."

Pfizer did not immediately respond to a request for comment.

"European leaders must not be allowed to legislate in complete opacity, and safeguards must be put in place," said French Member of the European Parliament Manon Aubry, among those lawmakers seeking more clarity on the pandemic-era contracts.

Transparency International, meanwhile, said it hoped the ruling would force the Commission to change what it called the institution's "restrictive attitude to freedom of information".

"This ruling is about more than transparency: it is about reinstating the institutional accountability the European Commission has been sorely lacking," said Shari Hinds, the organisation's policy officer on EU political integrity.

Reporting by Foo Yun Chee; Editing by Benoit Van Overstraeten and Joe Bavier

Our Standards: The Thomson Reuters Trust Principles.

Foo Yun Chee

Thomson Reuters

An agenda-setting and market-moving journalist, Foo Yun Chee is a 21-year veteran at Reuters. Her stories on high profile mergers have pushed up the European telecoms index, lifted companies' shares and helped investors decide on their next move. Her knowledge and experience of European antitrust laws and developments helped her break stories on Microsoft, Google, Amazon, Meta and Apple, numerous market-moving mergers and antitrust investigations. She has previously reported on Greek politics and companies, when Greece's entry into the eurozone meant it punched above its weight on the international stage, as well as on Dutch corporate giants and the quirks of Dutch society and culture that never fail to charm readers.